Study name |
D‐mannose for prophylaxis against urinary tract infection in spinal cord injury: pilot randomised control study |
Methods |
Study design
Study duration and follow‐up
Study dates
|
Participants |
General information
Country: New Zealand
Setting: single centre
Inclusion criteria: patients admitted to Auckland Spinal Rehab Unit. All new admissions to the spinal unit, neurogenic bladder needing catheter on admission; aged ≥ 14 years; females and males
Exclusion criteria: repeat admission, no evidence of neurogenic bladder on admission
Target sample size: 40
|
Interventions |
Treatment group
Control group
-
Standard care for neurogenic bladder practised in the spinal unit: catheter care, early commencement of intermittent catheterization program in appropriate cases, hygiene, good fluid intake with the aim of 1.5 to 2 litres and education
Co‐interventions or additional treatments
Follow‐up details
|
Outcomes |
-
Rate ratio of UTI: number of UTI/total catheter days
Number of UTI: will be assessed by clinical symptoms like temperature more than 38, pain, urinary leakage with positive urine culture
Catheter days: total number of days patients needing to use a catheter to manage their bladder
-
Frequency ratio of CUTI: number of episodes of CUTI between treatment and control group
-
Acute transfer to tertiary Hospital for UTI between two groups
-
Time to first UTI between both groups
-
Temperature‐associated CUTI (UTI symptoms and associated temperature elevation) between groups
|
Starting date |
Recruitment completed |
Contact information |
Dr Suresh Subramanian Auckland Spinal rehab unit 30 Bairds Road Otara 1640 Auckland New Zealand +64 9 2709000 Sureshbabu.Subramanian@middlemore.co.nz |
Notes |
|